August 2023 in “JAAD international” This study observed that most pediatric dermatologists prefer class 1 and 2 topical corticosteroids as first-line treatments for pediatric alopecia areata, with increasing use of JAK inhibitors as second-line therapy.
66 citations
,
February 2013 in “Pediatric Dermatology” This review summarizes the dermoscopic structures associated with infectious and inflammatory skin conditions and hair disorders in children but reports no new clinical results.
June 2023 in “Revista médica hondureña” In this study conducted at the Pediatric Hematology-Oncology Ward, 65% of hospitalized pediatric cancer patients developed dermatological lesions, predominantly alopecia and mucositis, possibly due to the administration of plant alkaloid chemotherapy, consistent with existing literature.
6 citations
,
May 2024 in “Clinical and Experimental Dermatology” According to this systematic review, children with alopecia areata experience significant psychosocial impacts, including anxiety, depression, and lower self-esteem, which are exacerbated by increased disease severity and affect quality of life, academic performance, and social interactions.
April 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This review reports that pediatric alopecia presents in various forms, with alopecia areata being the most common, and emphasizes the need for precise diagnosis and individualized management, including medical and psychossocial approaches, to address both the physical and emotional impact on affected children.
